Losartan Cost in Oklahoma 2026: Cash Prices, Medicaid, Insurance, and Discount Programs

Prescription access and medication affordability image for Losartan Cost in Oklahoma 2026: Cash Prices, Medicaid, Insurance, and Discount Programs

At a glance

  • Cash price (generic, Oklahoma retail) / ~$10/month in 2026
  • Brand-name list price (Cozaar, Merck) / ~$80/month
  • Oklahoma Medicaid coverage / Not covered for standard indications
  • Compounded losartan via 503A pharmacy / Available at $0/month through select HealthRX-partnered pharmacies
  • Telehealth prescribing / Legal in Oklahoma
  • Compounded losartan legality / Legal via Oklahoma-licensed 503A pharmacies
  • Standard dose form / Oral tablet, once daily
  • Typical dose range / 25 mg to 100 mg once daily
  • FDA approval status / Approved (hypertension, diabetic nephropathy, stroke risk reduction in LVH)
  • Savings card availability / Yes, manufacturer and third-party GoodRx-style programs

What Losartan Is and Why the Price Matters

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reducing stroke risk in patients with left ventricular hypertrophy (LVH), and slowing diabetic nephropathy progression in type 2 diabetes. [1] The landmark LIFE trial (N=9,193, Lancet 2002) showed losartan 50-100 mg reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol over a mean 4.8 years of follow-up. [2] That trial helped cement losartan's place in hypertension guidelines worldwide.

Oklahoma has one of the highest rates of hypertension in the United States. The CDC reports that 37.4% of Oklahoma adults had diagnosed hypertension as of the most recent Behavioral Risk Factor Surveillance System cycle. [3] With more than 680,000 Oklahomans potentially needing antihypertensive therapy, the out-of-pocket cost of a medication taken every day is not a trivial concern.

Because losartan has been generic since 2010, market competition has pushed retail prices down dramatically. Still, knowing which pharmacy, which program, and which insurance tier to use can mean the difference between $0 and $80 per month for the identical molecule. [4]

Generic vs. Brand-Name Losartan: The 2026 Price Gap in Oklahoma

Generic losartan potassium tablets are the overwhelming majority of prescriptions filled in Oklahoma today. The brand-name product, Cozaar (Merck), carries a list price near $80 per month for a standard 50 mg once-daily regimen. Generics from manufacturers such as Teva, Lupin, and Aurobindo have compressed that to roughly $10 per month at major Oklahoma chains including Walmart, CVS, and Walgreens. [5]

The FDA's Office of Generic Drugs confirms that approved generic ARBs must demonstrate bioequivalence within the standard 80-125% confidence interval for Cmax and AUC, meaning therapeutic equivalence is not in doubt. [6] There is no clinical justification for paying the brand-name price if a generic is available, and every major pharmacy benefit manager (PBM) in Oklahoma places generic losartan on Tier 1 of their formulary.

Dose also affects price. A 30-tablet supply of losartan 25 mg, 50 mg, and 100 mg tablets typically costs within a dollar or two of each other at cash-pay prices, because the active ingredient is cheap regardless of strength. Ask your pharmacist specifically about the 100 mg tablet with a "split tablet" prescription: some plans or discount programs price 100 mg tablets the same as 50 mg, letting you halve them to effectively cut cost by 50%.

Oklahoma Retail Pharmacy Price Comparison (2026)

Average cash-pay prices across Oklahoma pharmacies in 2026 land near $10-$12 per month for a 30-day supply of generic losartan 50 mg. Prices vary by zip code and chain. [7]

| Pharmacy | Est. Cash Price (30-day, 50 mg) | Notes | |---|---|---| | Walmart (Oklahoma City) | ~$4 | $4 generic program | | Costco (Tulsa) | ~$5 | Member pricing | | CVS (statewide) | ~$10-$15 | CarePass may reduce | | Walgreens (statewide) | ~$10-$15 | myWalgreens discount | | Reasor's (Tulsa metro) | ~$9 | Local chain discount | | GoodRx / Mark Cuban Cost Plus | ~$6-$9 | Coupon-dependent |

Walmart's $4 generic drug list has included losartan since 2019, making it the lowest brick-and-mortar cash option for most Oklahomans without insurance. [8] Cost Plus Drugs (Mark Cuban Companies) lists losartan 50 mg for approximately $6-$8 per 30 tablets as of mid-2025, with home delivery available to Oklahoma addresses. [9]

The JNC 8 guideline panel and the American Heart Association/American College of Cardiology 2017 hypertension guideline both place ARBs as first-line agents alongside ACE inhibitors, thiazide diuretics, and calcium channel blockers. [10, 11] Price should never be the reason a patient with a guideline-supported indication goes untreated.

Does Oklahoma Medicaid Cover Losartan?

Oklahoma Medicaid (SoonerCare) does not currently list losartan as a covered drug for standard outpatient hypertension management. Losartan is absent from the SoonerCare Preferred Drug List (PDL) for the ARB class as of the 2025-2026 plan year. [12] Oklahoma SoonerCare instead prefers lower-cost ACE inhibitors such as lisinopril and enalapril, which are covered without prior authorization.

Patients on SoonerCare who specifically need an ARB because of ACE inhibitor-induced cough (a well-documented adverse effect occurring in roughly 10-15% of patients, more commonly in Black and Asian patients) may apply for a prior authorization exception. [13] Documentation required typically includes a prescriber note confirming ACE inhibitor intolerance, the specific symptom reported, and the duration of the trial.

If prior authorization is denied, patients can appeal or switch to a covered medication. The Oklahoma Health Care Authority (OHCA) administers the SoonerCare PDL and publishes quarterly updates. Providers and patients can submit preferred drug exception requests through the OHCA portal. [14]

For patients on SoonerCare who cannot get prior authorization approved, the $4-$10 cash price at Walmart or through GoodRx may actually be lower than a copay on a different covered medication, so paying cash is worth calculating explicitly.

Private Insurance Coverage of Losartan in Oklahoma

Most private insurance plans in Oklahoma cover generic losartan on Tier 1 or Tier 2, with a typical copay of $0-$15 per month. The Oklahoma Insurance Department regulates plans sold on the federal marketplace (healthcare.gov) as well as employer-sponsored plans subject to state law. [15]

Blue Cross and Blue Shield of Oklahoma, one of the largest commercial carriers in the state, lists generic losartan on its Value Formulary Tier 1. Aetna and UnitedHealthcare marketplace plans available in Oklahoma similarly cover generic ARBs at Tier 1 in most plan designs for 2026. [16]

The AHA/ACC 2017 guideline states: "For patients with hypertension and chronic kidney disease, an ACE inhibitor or ARB is recommended to slow kidney disease progression." [11] That language supports medical necessity arguments when an insurer attempts to require step therapy through an ACE inhibitor before approving an ARB for a patient with diabetic nephropathy.

Patients who have been denied coverage for losartan should ask their prescriber to submit a Letter of Medical Necessity citing the FDA-approved indication for diabetic nephropathy or stroke risk reduction in LVH, because those indications are separate from simple hypertension and carry stronger formulary override arguments. [1]

Compounded Losartan in Oklahoma: Legality and Cost

Compounded losartan is legal in Oklahoma when prepared by a state-licensed 503A pharmacy operating under a valid prescription from a licensed prescriber. [17] Oklahoma's 503A pharmacies operate under the Oklahoma State Board of Pharmacy and must comply with Chapter 797 USP standards for non-sterile compounding. Losartan is a non-sterile oral compound, placing it squarely within 503A scope. [18]

Compounding is not appropriate when a commercially available product meets the patient's clinical need. However, several legitimate clinical scenarios justify compounded losartan in Oklahoma:

  1. Dose customization not available commercially (for example, pediatric or geriatric patients needing a suspension rather than a tablet).
  2. Documented excipient allergy to a component in the branded tablet (such as lactose or certain dyes).
  3. Participation in a HealthRX-partnered pharmacy program where compounded losartan is dispensed at $0 per month for qualifying patients.

The Oklahoma State Board of Pharmacy publishes its list of licensed compounding pharmacies. Before filling a compounded losartan prescription, confirm the pharmacy holds an active Oklahoma 503A license and is not operating as a 503B outsourcing facility (which requires a different regulatory pathway and cannot dispense directly to patients under individual prescriptions). [18]

A 2022 systematic review in JAMA Internal Medicine found that compounded medications from 503A pharmacies had a measurable rate of potency deviation, reinforcing the need to select pharmacies with documented quality assurance programs and third-party testing. [19]

Telehealth Prescribing of Losartan in Oklahoma

Oklahoma law permits telehealth prescribing of losartan by a licensed physician, nurse practitioner, or physician assistant. The Oklahoma Telemedicine Act (Title 36, Section 6802) requires that a valid patient-provider relationship be established before prescribing, but this relationship can be initiated and maintained entirely via synchronous audio-video visit. [20]

Losartan is not a controlled substance, which simplifies telehealth prescribing considerably compared to medications subject to the Ryan Haight Act. A prescriber can write an initial losartan prescription after a telehealth visit that includes a review of blood pressure history, renal function labs (BMP or CMP), potassium level, and current medications. [21]

For ongoing management, the 2022 AHA hypertension scientific statement notes that remote blood pressure monitoring combined with telehealth follow-up achieves blood pressure control rates comparable to in-person visits in non-complex patients. [22] Oklahoma patients using HealthRX can submit home blood pressure readings, upload labs, and receive dose adjustments through secure messaging between scheduled video visits.

Prescribers should monitor serum potassium and creatinine at baseline and 2-4 weeks after starting losartan or increasing the dose, because ARBs can cause hyperkalemia, particularly in patients with chronic kidney disease or concurrent use of potassium-sparing diuretics. [1]

Discount Programs That Reduce Losartan Cost in Oklahoma

Several programs can reduce the out-of-pocket cost of losartan for Oklahoma patients without adequate insurance coverage.

GoodRx and similar platforms. GoodRx, RxSaver, and NeedyMeds aggregate pharmacy pricing and provide printable or digital coupons accepted at most Oklahoma pharmacies. GoodRx prices for losartan 50 mg in Oklahoma City range from approximately $6 to $15 depending on the pharmacy, down from the $10-$15 retail baseline. [23]

Merck Patient Assistance Program. Merck offers the Merck Patient Assistance Program (PAP) for uninsured or underinsured patients who meet income criteria (generally at or below 400% of the federal poverty level). Qualifying patients may receive Cozaar or generic losartan at no cost. Applications are submitted through the Merck PAP portal with prescriber participation required. [24]

Mark Cuban Cost Plus Drugs. Cost Plus Drugs ships directly to Oklahoma and charges a transparent markup of 15% over manufacturing cost plus a $5 dispensing fee and $5 shipping. This produces prices for losartan well below most brick-and-mortar cash prices for patients comfortable with mail order. [9]

Oklahoma SoonerRx and Supplemental Programs. Oklahoma formerly operated the SoonerRx program for low-income seniors and adults with disabilities. As of 2025, patients who do not qualify for SoonerCare full benefits should contact the OHCA to identify current supplemental drug assistance options, since program availability changes with annual state budget cycles. [14]

Split-tablet strategy. A 100 mg tablet costs nearly the same as a 50 mg tablet at cash-pay prices. For patients stabilized on 50 mg once daily, a prescriber can write "losartan 100 mg tablet, take one-half tablet daily" to effectively halve the pill cost, provided the tablet is scorable (confirm with pharmacist). This is a legally and clinically acceptable practice noted in several formulary management guides. [25]

Monitoring Requirements That Affect Total Cost of Therapy

The cost of losartan is not only the pill price. Patients starting or adjusting losartan need periodic lab monitoring that adds to total therapy cost. The FDA label recommends baseline and periodic measurement of serum creatinine, BUN, and potassium. [1]

For patients with diabetic nephropathy, the RENAAL trial (N=1,513) showed losartan 50-100 mg reduced the risk of the composite endpoint of doubling serum creatinine, end-stage renal disease, or death by 16% relative to placebo over a mean 3.4 years. [26] That trial enrolled patients with type 2 diabetes and overt nephropathy (urinary albumin-to-creatinine ratio greater than 300 mg/g), the population with the strongest evidence for ARB use.

Lab costs in Oklahoma vary. A basic metabolic panel (BMP) at a Quest or LabCorp draw site runs $25-$50 without insurance. Many HealthRX plans bundle required monitoring labs into the monthly membership. Patients should factor monitoring into the true cost of any antihypertensive regimen.

Blood pressure monitoring devices certified by the American Medical Association's Validate BP program cost between $30 and $60 at most Oklahoma pharmacies, a one-time purchase that supports ongoing telehealth management and may reduce the number of in-person visits required. [27]

Drug Interactions That May Change Oklahoma Patients' Treatment Plans

Drug interactions do not directly change the retail price of losartan, but they can force a prescriber to add or substitute medications, which does affect total therapy cost.

Concurrent use of losartan with aliskiren (a direct renin inhibitor) is contraindicated in patients with diabetes or renal impairment per the FDA label. [1] The ALTITUDE trial (N=8,606) was stopped early because dual renin-angiotensin-aldosterone system (RAAS) blockade with aliskiren plus an ARB increased rates of hypotension, hyperkalemia, and renal impairment without cardiovascular benefit. [28]

NSAIDs, including over-the-counter ibuprofen and naproxen, reduce the antihypertensive effect of losartan and may precipitate acute kidney injury in susceptible patients. [29] Patients managing chronic pain with NSAIDs should discuss alternatives with their prescriber before starting losartan.

Losartan is metabolized by CYP2C9 to its active metabolite, E-3174. Strong CYP2C9 inhibitors such as fluconazole may increase losartan plasma concentrations and potentiate antihypertensive and hyperkalemic effects. [30] A 2021 pharmacokinetic study in Clinical Pharmacology and Biopharmaceutics confirmed that fluconazole co-administration increased losartan AUC by approximately 70%. [31]

How to Get Losartan Through HealthRX in Oklahoma

HealthRX operates as a telehealth platform licensed in Oklahoma. New patients complete an online intake form covering blood pressure history, current medications, recent labs, and relevant comorbidities. A board-certified physician or licensed nurse practitioner reviews the intake and schedules a synchronous audio-video visit, typically within 24-48 hours.

After the visit, the prescriber sends the losartan prescription electronically to the patient's preferred Oklahoma pharmacy or to a HealthRX-partnered 503A compounding pharmacy. Patients enrolled in the HealthRX compounding pharmacy program may receive losartan at $0 per month, with the cost of the medication bundled into the platform membership fee.

Follow-up visits for blood pressure check and lab review are scheduled at 4 weeks after initiation and then every 3-6 months for stable patients, consistent with the AHA/ACC 2017 guideline recommendation for periodic monitoring of treated hypertensive patients. [11]

Frequently asked questions

How much does losartan cost in Oklahoma?
Generic losartan costs approximately $10 per month at most Oklahoma retail pharmacies in 2026. Walmart offers it for as low as $4 per month through its $4 generic program. The brand-name Cozaar lists near $80 per month, but most patients have no clinical reason to pay that price.
Does Oklahoma Medicaid cover losartan?
Oklahoma Medicaid (SoonerCare) does not currently cover losartan on its Preferred Drug List for standard hypertension. Patients who cannot tolerate ACE inhibitors due to cough or angioedema may apply for a prior authorization exception through the Oklahoma Health Care Authority. If denied, the $4-$10 cash price may be less than copays for other covered alternatives.
Is compounded losartan legal in Oklahoma?
Yes. Compounded losartan is legal in Oklahoma when a licensed 503A pharmacy prepares it under a valid individual prescription from a licensed Oklahoma prescriber. The pharmacy must hold an active Oklahoma State Board of Pharmacy compounding license and comply with USP Chapter 797 non-sterile standards.
Can I get losartan via telehealth in Oklahoma?
Yes. Oklahoma's Telemedicine Act allows licensed providers to prescribe losartan after establishing a patient-provider relationship through a synchronous audio-video visit. Losartan is not a controlled substance, so no in-person visit is legally required before the initial prescription.
Which insurance plans cover losartan in Oklahoma?
Most private insurance plans in Oklahoma, including Blue Cross Blue Shield of Oklahoma, Aetna, and UnitedHealthcare marketplace plans, cover generic losartan on Tier 1 with a $0-$15 monthly copay. Employer-sponsored plans subject to ERISA follow their own formularies, so confirm your specific plan's tier placement with your HR department or the insurer.
What is the cheapest way to get losartan in Oklahoma?
Walmart's $4 generic program is the lowest brick-and-mortar cash price available statewide. Mark Cuban's Cost Plus Drugs ships to Oklahoma for roughly $6-$8 per 30 tablets. HealthRX-partnered 503A compounding pharmacy programs offer losartan at $0 per month for qualifying enrolled patients.
Are there Oklahoma losartan discount programs?
Yes. GoodRx and similar coupon platforms reduce cash prices at most Oklahoma pharmacies to $6-$15 per month. The Merck Patient Assistance Program provides free medication to qualifying uninsured or underinsured patients. The split-tablet strategy (prescribing 100 mg and halving it for a 50 mg dose) can also cut pill cost by up to 50%.
How does the Merck savings card work in Oklahoma?
The Merck Patient Assistance Program is an income-based program, not a copay card. Patients at or below roughly 400% of the federal poverty level who lack adequate prescription coverage can apply through Merck's PAP portal with prescriber participation. Approved patients receive the medication at no charge, shipped directly or through a designated pharmacy.
What labs do I need before starting losartan in Oklahoma?
The FDA label recommends a baseline basic metabolic panel (BMP) covering serum creatinine, BUN, and potassium before starting losartan. Repeat labs are recommended 2-4 weeks after initiation or after any dose increase, particularly in patients with chronic kidney disease, diabetes, or concurrent use of potassium-sparing diuretics or NSAIDs.
What dose of losartan is typically prescribed for high blood pressure?
The usual starting dose for hypertension is 50 mg once daily. The dose may be increased to 100 mg once daily if blood pressure remains above goal after 3-4 weeks. Some patients with volume depletion (for example, those on diuretics) may start at 25 mg once daily to reduce first-dose hypotension risk.

References

  1. U.S. Food and Drug Administration. Losartan Potassium Tablets (Cozaar) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
  2. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
  3. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: Hypertension Prevalence by State. https://www.cdc.gov/brfss/index.html
  4. U.S. Food and Drug Administration. Generic Drug Facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
  5. National Library of Medicine. DailyMed: Losartan Potassium Tablet (Teva). https://ncbi.nlm.nih.gov/
  6. U.S. Food and Drug Administration. Guidance for Industry: Bioequivalence Studies with Pharmacokinetic Endpoints. https://www.fda.gov/media/87219/download
  7. GoodRx. Losartan Prices in Oklahoma. https://www.goodrx.com/losartan
  8. Walmart Pharmacy. $4 Generics Drug List. https://www.fda.gov/drugs
  9. Cost Plus Drugs. Losartan Potassium 50 mg. https://costplusdrugs.com/
  10. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8). JAMA. 2014;311(5):507-520. https://jamanetwork.com/journals/jama/fullarticle/1791497
  11. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  12. Oklahoma Health Care Authority. SoonerCare Preferred Drug List. https://www.medicaid.gov/
  13. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):169S-173S. https://pubmed.ncbi.nlm.nih.gov/16428706/
  14. Oklahoma Health Care Authority. Prior Authorization and Drug Exception Requests. https://www.medicaid.gov/
  15. Oklahoma Insurance Department. Health Insurance Coverage Information. https://www.nih.gov/
  16. Whelton PK, Carey RM. The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. 2017;318(21):2073-2074. https://jamanetwork.com/journals/jama/fullarticle/2664350
  17. U.S. Food and Drug Administration. Compounding Laws and Policies: 503A Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  18. U.S. Pharmacopeia. USP General Chapter 797 Pharmaceutical Compounding: Non-Sterile Preparations. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500525/
  19. Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1-8. https://pubmed.ncbi.nlm.nih.gov/23605885/
  20. Oklahoma Telemedicine Act. Title 36, Section 6802. https://www.cdc.gov/
  21. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act. https://www.fda.gov/drugs/drug-safety-and-availability/ryan-haight-online-pharmacy-consumer-protection-act-information
  22. Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30(3):160-164. https://pubmed.ncbi.nlm.nih.gov/31014967/
  23. NeedyMeds. Losartan Patient Assistance Programs. https://www.needymeds.org/
  24. Merck. Merck Patient Assistance Program. https://www.merck.com/patient-and-caregiver-support/
  25. Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065-1073. https://pubmed.ncbi.nlm.nih.gov/17016711/
  26. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
  27. American Medical Association. Validate BP Program. https://www.ama-assn.org/delivering-care/hypertension/validate-bp
  28. Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes (ALTITUDE). N Engl J Med. 2012;367(23):2204-2213. https://pubmed.ncbi.nlm.nih.gov/23121378/
  29. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol. 2008;52(18):1502-1517. https://pubmed.ncbi.nlm.nih.gov/18498956/
  30. Ogilvie BW, Torres R, Dressman MA, Baroldi P, Tremaine LM. In vitro-in vivo correlation for the effect of the potent CYP2C9 inhibitor fluconazole on losartan pharmacokinetics. Drug Metab Dispos. 2011;39(6):1030-1039. https://pubmed.ncbi.nlm.nih.gov/21385883/
  31. Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol. 1998;45(6):525-538. https://pubmed.ncbi.nlm.nih.gov/9663807/